Desmoglein‐2 expression is an independent predictor of poor prognosis patients with multiple myeloma

Multiple myeloma (MM) is the second most common haematological malignancy and is an incurable disease of neoplastic plasma cells (PC). Newly diagnosed MM patients currently undergo lengthy genetic testing to match chromosomal mutations with the most potent drug/s to decelerate disease progression. W...

Descripción completa

Detalles Bibliográficos
Autores principales: Ebert, Lisa M., Vandyke, Kate, Johan, M. Zahied, DeNichilo, Mark, Tan, Lih Y., Myo Min, Kay K., Weimann, Benjamin M., Ebert, Brenton W., Pitson, Stuart M., Zannettino, Andrew C. W., Wallington‐Beddoe, Craig T., Bonder, Claudine S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8936512/
https://www.ncbi.nlm.nih.gov/pubmed/34245117
http://dx.doi.org/10.1002/1878-0261.13055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8936512/
https://www.ncbi.nlm.nih.gov/pubmed/34245117
http://dx.doi.org/10.1002/1878-0261.13055

Ejemplares similares